Immune Checkpoint Inhibitor-Induced Diabetic Ketoacidosis: A Report of Four Cases and Literature Review

Immune checkpoint inhibitors (ICIs) have been widely used in the treatment of various types of cancers worldwide. Although ICI-related autoimmune diabetes is a rare complication, it can be associated with a life-threatening condition, diabetic ketoacidosis (DKA). Here, we report the cases of four pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, A Ram, Yoon, Jee Hee, Kim, Hee Kyung, Kang, Ho-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997462/
https://www.ncbi.nlm.nih.gov/pubmed/32047478
http://dx.doi.org/10.3389/fendo.2020.00014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997462/
https://www.ncbi.nlm.nih.gov/pubmed/32047478
http://dx.doi.org/10.3389/fendo.2020.00014

Ejemplares similares